Oxo-4-methylpentanoic acid directs the metabolism of GABA into the Krebs cycle in rat pancreatic islets

Biochem J. 2006 Nov 15;400(1):81-9. doi: 10.1042/BJ20060173.

Abstract

OMP (oxo-4-methylpentanoic acid) stimulates by itself a biphasic secretion of insulin whereas L-leucine requires the presence of L-glutamine. L-Glutamine is predominantly converted into GABA (gamma-aminobutyric acid) in rat islets and L-leucine seems to promote its metabolism in the 'GABA shunt' [Fernández-Pascual, Mukala-Nsengu-Tshibangu, Martín del Río and Tamarit-Rodríguez (2004) Biochem. J. 379, 721-729]. In the present study, we have investigated how 10 mM OMP affects L-glutamine metabolism to uncover possible differences with L-leucine that might help to elucidate whether they share a common mechanism of stimulation of insulin secretion. In contrast with L-leucine, OMP alone stimulated a biphasic insulin secretion in rat perifused islets and decreased the islet content of GABA without modifying its extracellular release irrespective of the concentration of L-glutamine in the medium. GABA was transaminated to L-leucine whose intracellular concentration did not change because it was efficiently transported out of the islet cells. The L-[U-14C]-Glutamine (at 0.5 and 10.0 mM) conversion to 14CO2 was enhanced by 10 mM OMP within 30% and 70% respectively. Gabaculine (250 microM), a GABA transaminase inhibitor, suppressed OMP-induced oxygen consumption but not L-leucine- or glucose-stimulated respiration. It also suppressed the OMP-induced decrease in islet GABA content and the OMP-induced increase in insulin release. These results support the view that OMP promotes islet metabolism in the 'GABA shunt' generating 2-oxo-glutarate, in the branched-chain alpha-amino acid transaminase reaction, which would in turn trigger GABA deamination by GABA transaminase. OMP, but not L-leucine, suppressed islet semialdehyde succinic acid reductase activity and this might shift the metabolic flux of the 'GABA shunt' from gamma-hydroxybutyrate to succinic acid production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldehyde Oxidoreductases / antagonists & inhibitors
  • Aldehyde Oxidoreductases / metabolism
  • Amino Acids / metabolism
  • Animals
  • Cerebellum / drug effects
  • Cerebellum / enzymology
  • Cerebellum / metabolism
  • Citric Acid Cycle / drug effects*
  • Cyclohexanecarboxylic Acids / pharmacology
  • Glucose / pharmacology
  • Glutamine / metabolism
  • Glutamine / pharmacology
  • In Vitro Techniques
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / drug effects*
  • Islets of Langerhans / metabolism
  • Keto Acids / pharmacology*
  • Leucine / pharmacology
  • Male
  • Oxidation-Reduction / drug effects
  • Oxygen / metabolism
  • Rats
  • Rats, Wistar
  • Succinate-Semialdehyde Dehydrogenase / antagonists & inhibitors
  • Succinate-Semialdehyde Dehydrogenase / metabolism
  • Time Factors
  • Transaminases / antagonists & inhibitors
  • Transaminases / metabolism
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Amino Acids
  • Cyclohexanecarboxylic Acids
  • Insulin
  • Keto Acids
  • Glutamine
  • gabaculine
  • gamma-Aminobutyric Acid
  • alpha-ketoisocaproic acid
  • Aldehyde Oxidoreductases
  • Succinate-Semialdehyde Dehydrogenase
  • Transaminases
  • Leucine
  • Glucose
  • Oxygen